- Home
- LSE vs MIST Comparison
LSE vs MIST Comparison
Compare LSE & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSE
- MIST
- Stock Information
- Founded
- LSE 2007
- MIST 2003
- Country
- LSE China
- MIST Canada
- Employees
- LSE N/A
- MIST N/A
- Industry
- LSE Metal Fabrications
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- LSE Industrials
- MIST Health Care
- Exchange
- LSE Nasdaq
- MIST Nasdaq
- Market Cap
- LSE 84.0M
- MIST 100.3M
- IPO Year
- LSE 2024
- MIST N/A
- Fundamental
- Price
- LSE $5.00
- MIST $1.85
- Analyst Decision
- LSE
- MIST Strong Buy
- Analyst Count
- LSE 0
- MIST 3
- Target Price
- LSE N/A
- MIST $13.00
- AVG Volume (30 Days)
- LSE 655.2K
- MIST 355.1K
- Earning Date
- LSE 01-01-0001
- MIST 11-12-2024
- Dividend Yield
- LSE N/A
- MIST N/A
- EPS Growth
- LSE 174.44
- MIST N/A
- EPS
- LSE 0.82
- MIST N/A
- Revenue
- LSE $83,737,603.00
- MIST N/A
- Revenue This Year
- LSE N/A
- MIST N/A
- Revenue Next Year
- LSE N/A
- MIST N/A
- P/E Ratio
- LSE $6.07
- MIST N/A
- Revenue Growth
- LSE 167.90
- MIST N/A
- 52 Week Low
- LSE $3.76
- MIST $1.12
- 52 Week High
- LSE $5.88
- MIST $2.40
- Technical
- Relative Strength Index (RSI)
- LSE N/A
- MIST 54.63
- Support Level
- LSE N/A
- MIST $1.68
- Resistance Level
- LSE N/A
- MIST $1.86
- Average True Range (ATR)
- LSE 0.00
- MIST 0.08
- MACD
- LSE 0.00
- MIST -0.01
- Stochastic Oscillator
- LSE 0.00
- MIST 73.91
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).